46.5 F
New York
Friday, December 4, 2020

Tiziana [NASDAQ: TLSA] Receives New US Patent For TZLS-501 In COVID-19 Treatment

Must read

Ring [NYSEMKT: REI] Energy Started Drilling Operation In New Horizontal Well

Ring Energy declared that the company has started operations on its new well. The company told that in ten months, it finally initiated...

KKR [NYSE: KKR] Purchased Two Industrial Properties Of Worth $171Million

KKR & Co. Inc. announced that it purchased two properties in texas for distribution purposes. The industrial properties total an area of...

EchoStar [NASDAQ: SATS] Partners With JT And Brings A Single Terminal For Network Connectivity To Market

EchoStar Corp.  declared that it has collaborated with Jersey Telecom so that it can provide its clients in the United Kingdom and Europe...

Capstone [NASDAQ: CPST] Receives An 800Kw Microturbine Order From Costa

Capstone Turbine Corp. declared that it has acquired an order of 800KW microturbine from the Costa Group. The request was obtained by the...

Tiziana Life Sciences Plc [NASDAQ: TLSA] announced Monday it has received a patent for methods and use of fully human monoclonal antibody from the US Patent and Trademark office.

The fully human monoclonal antibody recognizes both the IL-6 receptor and IL-6 receptor complex with IL-6 (IL-6R/IL-6) for prophylactic and therapeutic intervention for human diseases.

The patent will be expected to publish by the USPTO on September 1, 2020. This additional payment on TZLS-501 is of particular significance for the treatment of COVID-19 and other pulmonary disorders such as acute respiratory distress syndrome (ARDS).

Shares of Tiziana Life Sciences has dropped 4.40% at $3.91 during the trading of Friday. It has day low range of $3.62 and a day high range of 4.14.

During the past 52-weeks of trading, this company’s stocks have fluctuated between the low of $0.62 & a high of $12.17. Tiziana has moved up 534.74% and moved down -67.87%.

This company has 52-weeks low range of 0.62 and a high range of $12.17.

Tiziana has trading volume of 809.24K as compared to the average volume of 1.23 million. Its total market capitalization is 372.54 million.

The major feature of TZLS-501 is that it acts via a dual mechanism. It not only inhibits IL-6R signaling but also reducing circulating levels of IL-6. This distinctive feature of TZLS-501, a fully human anti-IL-6R mAb, makes it suitable for the treatment of COVID-19 and ARDS. 

More articles

Latest article

Vodafone [NASDAQ: VOD] and RingCentral signs a partnership to provide next-generation services

Vodafone signed a strategic alliance with Ring Central . The association will modify business connections and alliances. The enterprises have joined hands to...

Salesforce [NYSE: CRM] Enters A Deal To Acquire Slack

Salesforce engages in a contract to buy Slack at a worth of $27.7B. This purchase to build an operating system for the...

Xilinx [NASDAQ: XLNX] Announced That It Acquired Falcon Computing

Xilinx Inc. declared that it has purchased falcon Computing Solutions to make flexible computing more accessible and easily adapted by computer programmers. The...

Luokung Corp. [NASDAQ: LKCO] To Acquire EMG For RMB 836 Million

Luokung Technologies Corp. a location-based service company has agreed to buy EMG technologies for Ren Min Bi  836 million. The company will pay...

Nokia [NYSE: NOK] Extends Collaboration With AT&T to Deliver Seamless IoT Connectivity

Nokia Corp. declared that the company has extended its contract with AT&T . The collaboration among the companies can supply and provide an...

Wendy [NASDAQ: WEN] Strikes A Deal With Rebel Foods To Open 250 Cloud Kitchens.

Wendy’s Co. and Rebel foods have partnered to open about 250 cloud kitchens in India. These kitchens will only serve the customer with...

Tesla [NASDAQ: TSLA] Recalls 9537 SUV’s Because Of Manufacturing Issues

Tesla Inc. has released safety recall orders for more than 9500 of its vehicle in the United States. The vehicles include Model Xs...

Northrop [NYSE:NOC] awarded a deal of $4.8B for Global Hawk Aircraft

Northrop Gruman Corp. has been awarded a deal to perform development, transformation, retrofit, and sustenance activities for the Global Hawk Program. This deal...